Ventricular Assist Device Market is expected to reach USD 2,464.9 million by 2024, at a CAGR 11.4%
The major factors that drive the growth of the Global Ventricular Assist Device Market include increase in incidence of patients with heart failure and shortage of heart donors. In accordance with the estimates of the American Heart Association, approximately 5.5 million individuals are affected by heart failure in the U.S. In addition, in the U.S., approximately 670,000 new cases of heart failure are diagnosed each year. Moreover, it is estimated that in the U.S., approximately 5.7 million patients of age 20 are affected with heart failure, while 30% of patients are below the age of 60.
Some of the key applications in the foot orthotics insole market include Bridge-to-transplant (BTT), Destination Therapy (DT) and others. Bridge-to-transplant (BTT) segment accounted for over 52.2% share of total sales generated in 2018. Destination Therapy (DT) segment is another leading segment of Ventricular Assist Device market and it accounted for over 30% share of total market in 2018.
The report offers an exhaustive analysis of the competitive landscape including thorough company profiling of top players such as- AbioMed, Abbott (Thoratec), Medtronic (HeartWare), Berlin Heart etc.
This market research report is covered different regions like North America, Europe, Asia Pacific, Middle East & Africa, and Latin America etc. Major Countries are United States, Canada, Germany, France, United Kingdom, Russia, Italy, Spain, Rest of Europe, China etc.
Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts.
Order a copy of Global Ventricular Assist Device Market Report 2019 @:
A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either too partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.
This Report Studies Ventricular Assist Device Market regulatory policies and macroeconomic factors are determined in Ventricular Assist Device industry evolution and predictive analysis.
— MarketInsightsReport (@MIRresearch) July 16, 2019